WINSOME BOYKIN: Open Payments
NPI 1891393765 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 21 payments from 12 companies in 2025. Trend: 2023 $117 · 2024 $124 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $79 |
| Viatris Specialty LLC | 4 | $78 |
| Lundbeck LLC | 2 | $57 |
| Lilly USA, LLC | 2 | $52 |
| ABBVIE INC. | 2 | $44 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Amgen Inc. | 1 | $31 |
| HARMONY BIOSCIENCES LLC | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
Products named: YUPELRI, VYEPTI, MOUNJARO, OTEZLA, WAKIX, TEZSPIRE, Rybelsus, NUCALA.
Industry payments across MD — which companies pay providers there.
